Androstenediol 17β-acetate

Add links
Source: Wikipedia, the free encyclopedia.
Androstenediol 17β-acetate
Clinical data
Other namesAndrostenediol 17-acetate; 5-Androstenediol 17β-acetate; Androst-5-ene-3β,17β-diol 17β-acetate
Identifiers
  • [(3S,8R,9S,10R,13S,14S,17S)-3-Hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
JSmol)
  • CC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C
  • InChI=1S/C21H32O3/c1-13(22)24-19-7-6-17-16-5-4-14-12-15(23)8-10-20(14,2)18(16)9-11-21(17,19)3/h4,15-19,23H,5-12H2,1-3H3/t15-,16-,17-,18-,19-,20-,21-/m0/s1
  • Key:BMDNPBLUVJZAEA-BPSSIEEOSA-N

Androstenediol 17β-acetate, or 5-androstenediol 17β-acetate, also known as androst-5-ene-3β,17β-diol 17β-acetate, is a

5-androstenediol (androst-5-ene-3β,17β-diol) – which was never marketed.[1][2]

See also

References

  1. ISBN 978-1-4757-2085-3
    .
  2. ^ "The detection and confirmation of androstenediol abuse in athletes". World Anti Doping Agency. Retrieved 2023-11-02.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Androstenediol_17β-acetate&oldid=1184633303"